rxstat › Prices in Saskatchewan › Faricimab

Faricimab (Vabysmo) price and coverage in Saskatchewan

Faricimab 6 mg/0.05ml solution lists at $225.00 per billed unit in Saskatchewan on the Saskatchewan Drug Plan's price list (Nov 1, 2026), before the pharmacy's dispensing fee.

Faricimab is covered by the Saskatchewan Drug Plan only under Exception Drug Status (EDS): your prescriber has to request coverage, and it applies to patients who meet set criteria.

Provinces bill this product in different units (per mL, per pen or per vial), so their prices are not directly comparable.

Price by strength in Saskatchewan

Strength and formLowest priceBrand
6 mg/0.05ml Solution1 product · special approval$225.00/unit–
All 1 products listed in Saskatchewan
ProductPriceCoverage
6 mg/0.05ml Solution
VabysmoHLR · DIN 02554003$225.00/unitSpecial approval

What you'll pay at the pharmacy

These are the prices the Saskatchewan Drug Plan lists for the drug itself. The pharmacy adds a dispensing fee and sometimes a markup, so paying cash costs more. If you have coverage, your share depends on your deductible and co-pay.

Shortage status

No active shortage is reported for Faricimab in Canada. Full drug page.

Faricimab price in other provinces

Common questions

How much does Faricimab cost in Saskatchewan?

Faricimab 6 mg/0.05ml solution lists at $225.00 per billed unit in Saskatchewan on the Saskatchewan Drug Plan's price list (Nov 1, 2026), before the pharmacy's dispensing fee.

Is Faricimab covered in Saskatchewan?

Faricimab is covered by the Saskatchewan Drug Plan only under Exception Drug Status (EDS): your prescriber has to request coverage, and it applies to patients who meet set criteria.

Is Faricimab cheaper in another province?

For 6 mg/0.05ml solution, listed prices run from $1350.00 to $1350.00 across 2 provinces. Public plans only cover their own residents, though.

Source: Saskatchewan Drug Plan Formulary (Nov 1, 2026). Public plan list prices per unit, before pharmacy fees and markup. This page is not medical advice.